Michael Stark is an obstetrician and gynecologist, with a particular interest in High-Risk Pregnancies and gynecological oncology. He is the founder of the International Oncology Advisory Board and the VIEZION project, which combines targeted chemotherapy, PIF, immunology, and stem-cell therapy to improve post-surgical oncological treatment. He introduced a modified evidence based Cesarean Section which is now in use in several countries and has also made significant contributions to surgery by modifying operations such as vaginal and abdominal hysterectomy, and by promoting the concept of single-entry natural orifice surgery. He conducted surgical workshops in several countries, including Kazakhstan, Kyrgyzstan, Vietnam, Laos, Armenia, Germany. The Netherlands, Sweden, Greece, Italy, Hungary, Turkey, Spain, Ukraine, Russia, China, India, Senegal, Kenya, Burkina Faso, Croatia, Serbia, and Bosnia Herzegovina. Between 1982 and 2000, Dr. Stark served as the medical director and head of Obstetrics and Gynecology at the MisgavLadach hospital in Jerusalem. From 2001 to 2010, he was the chairman of the gynecological departments of the HELIOS hospital group in Germany and Austria. Between 2011 and 2013, he acted as the scientific advisor of the USP hospital in Mallorca, Spain. He was also the scientific director of the new European surgical robotic system (TELELAP) in Milan, Italy, between 2012 and 2015. From 2016 to 2020, he served as the scientific consultant of the ELSAN hospital group in France. Dr. Stark is since 2004 the President of the New European Surgical Academy (NESA), an international inter-disciplinary surgical organization with members in 60 countries. Since 2017 he is a scientist at the university hospital "Charite" in Berlin, and since 2018 the vice president of the Chinese Perinatology Association. In 2011, he was nominated the Medico Del Anno (Doctor of the Year) in Italy, and he is an Honorary Member of the French, Polish, Russian, Serbian-Austrian, and Italian Gynecological Associations. He is a professor for robotics at the University of Adana, Turkey, and an Honorary Professor at the University of Chisinau. Dr. Stark has over 230publications, as well as a book and several book chapters. Dr. Stark has also held visiting professor positions at several countries, including the Universities of Toronto, Moscow, Beijing, Milan, Adana, Uppsala, and the Weill-Cornell University hospital in New York.

Dr. Lindheim is Professor of Obstetrics and Gynecology at both Wright State University, Boonshoft School of Medicine in Dayton, Ohio and the University of Central Florida in Orlando, Florida, as well as Visiting Professor of Shanghai Jiao Tong University School of Medicine in Shanghai, China. He graduated from Temple School of Medicine and was a resident at Pennsylvania Hospital in Philadelphia. Dr. Lindheim completed a fellowship in Reproductive Endocrinology and Infertility at the University of Southern California, his Masters in Medical Management from Tulane University, School of Public Health and Tropical Medicine, and is currently Board Certified in both Ob/Gyn and Reproductive Endocrinology and Infertility. He previously served on as the Board of Directors for ASRM and is Past President for the Society of Reproductive Surgeons. Dr. Lindheim has a major interest in In vitro fertilization, oocyte donation, embryo donation and surrogacy. He is a well-recognized expert in the field of minimally invasive reproductive surgery and has over 250 scientific publications, and book chapters and is Associate Editor for Fertility Sterility. His research focuses upon embryo implantation, minimally invasive reproductive surgery, and Polycystic Ovarian Syndrome (PCOS).

Willie Sai Ho Chan ( Dr Chan ) LLB, MD, grew up in Hong Kong and received his Bachelor's degree (LLB) from the China University of Political Science and Law in Beijing, China, and Doctor of Medicine (MD) from the China Medical University in Taiwan, China. He is currently working as Fellow, Professor and National Representative of the European Association for Predictive, Preventive and Personalised Medicine ( EPMA, Brussels, Belgium ) in Taiwan, China. He acts as co-ordinator among other countries to promote the aim of the Association. He is an inter- and multi- disciplinar healthcare professional with increasing international recognition. His main paper " Taiwan's Healthcare Report 2010 " ( EPMA Journal 2010 ), was published in the book " Healthcare Overview " ( Springer 2012 ). His works is cited in many other journals and books. His work aims at driving forward research in the field of medicine by providing high-quality evidence based papers for academics, researchers, and other related health professionals. His prime research areas include Chinese and Western medicine, genetics, and other various related fields.

Medical doctor graduated from the Faculty of Medicine of USP (FMUSP); Medical Residency in General Surgery and Endoscopy at the Hospital das Clínicas of FMUSP; Fellow researcher in 2014 at Harvard Medical School New Research Building, USA; Current Preceptor and Fellow of Advanced Endoscopy at Hospital das Clínicas of FMUSP.